Addiction warnings on opioid and z-drug packaging to be strengthened
Abstract
Warnings on the risk of dependency and addiction for gabapentinoids, benzodiazepines and z-drugs are to be strengthened, following a safety review by the medicines regulator. The Medicines and Healthcare products Regulatory Agency (MHRA) announced on 8 January 2026 that packaging and patient information leaflets for the drugs would be updated to include the warning “may […]
Fields of Study & Subjects
Pharmaceutical Quality and Counterfeiting
Forensic Toxicology and Drug Analysis
Pharmaceutical studies and practices
Publication details
- Journal / source
- Pharmaceutical journal/The pharmaceutical journal
- Publication date
- 1 January 2026